This isn't a case of isolated reporting lapses the FDA found that the company's written protocols were themselves the problem
That makes dose calculations straightforward, with no repeating decimals, no rounding concerns
while all three treated groups had benefits as assessed by looking at liver fat area and triglycerides, the Sema + -MSTN/-ActA combination (which had the largest decreases in overall body fat composition) also had the largest benefits in terms of these liver measures (Fig
OConnells 2022 EM Ottawa Blog Post on Pelvic Exams in the ED here, where she provided us with a low-risk checklist for patients that may safely forgo the ED pelvic exam (1), including those who have: A confirmed 1 st trimester IUP Only light bleeding with stable VS Minimal pain controlled with OTC analgesia No suspicion for alternate etiology (eg
Rodbard HW, Rosenstock J, Canani LH, Deerochanawong C, Gumprecht J, Lindberg S, Lingvay I, Sndergaard AL, Treppendahl MB, Montanya E, PIONEER 2 Investigators